NBIX vs. DHR
Compare and contrast key facts about Neurocrine Biosciences, Inc. (NBIX) and Danaher Corporation (DHR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NBIX or DHR.
Correlation
The correlation between NBIX and DHR is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
NBIX vs. DHR - Performance Comparison
Loading data...
Key characteristics
NBIX:
-0.29
DHR:
-0.70
NBIX:
-0.16
DHR:
-0.77
NBIX:
0.97
DHR:
0.90
NBIX:
-0.31
DHR:
-0.48
NBIX:
-0.70
DHR:
-1.12
NBIX:
19.10%
DHR:
17.04%
NBIX:
41.81%
DHR:
29.51%
NBIX:
-97.21%
DHR:
-65.30%
NBIX:
-21.44%
DHR:
-30.79%
Fundamentals
NBIX:
$11.45B
DHR:
$135.78B
NBIX:
$2.95
DHR:
$5.16
NBIX:
39.22
DHR:
36.77
NBIX:
0.27
DHR:
1.90
NBIX:
4.75
DHR:
5.70
NBIX:
4.75
DHR:
2.72
NBIX:
$2.41B
DHR:
$23.82B
NBIX:
$2.37B
DHR:
$14.23B
NBIX:
$539.80M
DHR:
$7.17B
Returns By Period
In the year-to-date period, NBIX achieves a -11.77% return, which is significantly higher than DHR's -12.38% return. Over the past 10 years, NBIX has underperformed DHR with an annualized return of 11.24%, while DHR has yielded a comparatively higher 19.04% annualized return.
NBIX
-11.77%
32.53%
-5.30%
-11.90%
1.10%
11.24%
DHR
-12.38%
6.41%
-17.22%
-20.36%
7.68%
19.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NBIX vs. DHR — Risk-Adjusted Performance Rank
NBIX
DHR
NBIX vs. DHR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
NBIX vs. DHR - Dividend Comparison
NBIX has not paid dividends to shareholders, while DHR's dividend yield for the trailing twelve months is around 0.56%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DHR Danaher Corporation | 0.56% | 0.47% | 0.43% | 0.38% | 0.26% | 0.32% | 0.44% | 0.62% | 0.60% | 36.46% | 0.80% | 0.47% |
Drawdowns
NBIX vs. DHR - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than DHR's maximum drawdown of -65.30%. Use the drawdown chart below to compare losses from any high point for NBIX and DHR. For additional features, visit the drawdowns tool.
Loading data...
Volatility
NBIX vs. DHR - Volatility Comparison
Neurocrine Biosciences, Inc. (NBIX) and Danaher Corporation (DHR) have volatilities of 11.22% and 10.69%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
NBIX vs. DHR - Financials Comparison
This section allows you to compare key financial metrics between Neurocrine Biosciences, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NBIX vs. DHR - Profitability Comparison
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Neurocrine Biosciences, Inc. reported a gross profit of 563.40M and revenue of 572.60M. Therefore, the gross margin over that period was 98.4%.
DHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Danaher Corporation reported a gross profit of 3.51B and revenue of 5.74B. Therefore, the gross margin over that period was 61.2%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Neurocrine Biosciences, Inc. reported an operating income of 23.60M and revenue of 572.60M, resulting in an operating margin of 4.1%.
DHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Danaher Corporation reported an operating income of 1.27B and revenue of 5.74B, resulting in an operating margin of 22.2%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Neurocrine Biosciences, Inc. reported a net income of 7.90M and revenue of 572.60M, resulting in a net margin of 1.4%.
DHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Danaher Corporation reported a net income of 954.00M and revenue of 5.74B, resulting in a net margin of 16.6%.